Anticancer Drugs Durvalumab Oncology Pharmacology Physiotherapy

Durvalumab (Warnings-29)

In this article we will discuss Durvalumab (Warnings-29)

In this article, we will discuss Durvalumab (Warnings-29). So, let’s get started.

Nervous system: Meningitis, encephalitis, myelitis and demyelination, myasthenic syndrome/myasthenia gravis (including exacerbation), Guillain-Barré syndrome, nerve paresis, and autoimmune neuropathy.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.